Azactam and Dyspnea exacerbated - a phase IV clinical study of FDA data

Summary:

Dyspnea exacerbated is reported as a side effect among people who take Azactam (aztreonam), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Cipro, and have Pain.

The phase IV clinical study analyzes which people have Dyspnea exacerbated when taking Azactam. It is created by eHealthMe based on reports of 1,039 people who have side effects when taking Azactam from the FDA, and is updated regularly.

What is Azactam?

Azactam has active ingredients of aztreonam. eHealthMe is studying from 1,044 Azactam users. Check the latest studies of Azactam.

What is Dyspnea exacerbated?

Dyspnea exacerbated is found to be associated with 3,343 drugs and 1,659 conditions by eHealthMe. Check the latest studies of Dyspnea exacerbated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

1,039 people reported to have side effects when taking Azactam.
Among them, 47 people (4.52%) have Dyspnea exacerbated.

Could Azactam cause Dyspnea exacerbated?

Among these 47 people:

How long have people been on Azactam when they have Dyspnea exacerbated? *

What is the gender of people who have Dyspnea exacerbated when taking Azactam? *

female: 51.11 %
male: 48.89 %

What is the age of people who have Dyspnea exacerbated when taking Azactam? *

What are other drugs people take besides Azactam? *

What are other side effects people have besides Dyspnea exacerbated? *

Fever: 21 people, 44.68%
Weakness: 14 people, 29.79%
Urticaria (rash of round, red welts on the skin that itch intensely): 14 people, 29.79%
Diarrhea: 13 people, 27.66%
Hypotension (abnormally low blood pressure): 13 people, 27.66%
Fatigue (feeling of tiredness): 13 people, 27.66%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 12 people, 25.53%
Chest Pain: 12 people, 25.53%
Cough: 12 people, 25.53%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 11 people, 23.40%

What are the existing conditions these people have? *

Pain: 12 people, 25.53%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 19.15%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 8 people, 17.02%
Nausea (feeling of having an urge to vomit): 7 people, 14.89%
Cough: 7 people, 14.89%
Constipation: 7 people, 14.89%
Faeces Hard: 6 people, 12.77%
Fibromyalgia (a long-term condition which causes pain all over the body): 6 people, 12.77%
Cystic Fibrosis Pancreatic (fibrosis with cyst in the pancreas): 6 people, 12.77%
Cystic Fibrosis Lung (fibrosis with cyst in the lung): 6 people, 12.77%

* Approximation only. Some reports may have incomplete information.

Do you take Azactam and have Dyspnea exacerbated?

- Check whether Dyspnea exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azactam:

Azactam (1,044 reports)

Browse all side effects of Azactam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (3,343 drugs)

Browse all the conditions that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (1,659 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aztreonam (the active ingredients of Azactam) and Azactam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.